Author

Ciro Celsa

Screening and HCC diagnosis in the area of NASH
Screening and HCC diagnosis in the area of NASH

Ciro Celsa

OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS
OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS

Ciro Celsa  et al.

PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS

Ciro Celsa  et al.

REMOTE MONITORING IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS FROM A SURVEY PERFORMED DURING COVID-19 OUTBREAK
REMOTE MONITORING IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS FROM A SURVEY PERFORMED DURING COVID-19 OUTBREAK

Ciro Celsa  et al.

TELEMEDICINE IS AN EFFECTIVE TOOL TO MONITOR DISEASE ACTIVITY IN IBD PATIENTS IN THE COVID-19 ERA: A SINGLE CENTRE EXPERIENCE BASED ON OBJECTIVE DATA
TELEMEDICINE IS AN EFFECTIVE TOOL TO MONITOR DISEASE ACTIVITY IN IBD PATIENTS IN THE COVID-19 ERA: A SINGLE CENTRE EXPERIENCE BASED ON OBJECTIVE DATA

Ciro Celsa  et al.

AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY
AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY

Ciro Celsa  et al.

TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS
TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS

Ciro Celsa  et al.

COMPARATIVE EFFICACY OF SECOND-LINE THERAPIES IN ULCERATIVE COLITIS: A MONOCENTRIC EXPERIENCE FROM A TERTIARY REFERRAL CENTER
COMPARATIVE EFFICACY OF SECOND-LINE THERAPIES IN ULCERATIVE COLITIS: A MONOCENTRIC EXPERIENCE FROM A TERTIARY REFERRAL CENTER

Ciro Celsa  et al.

Item 1 - 8 / 8
1